{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-054867","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.774436+00:00","generated_at":"2026-05-20T04:25:19.459775+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"TELA Bio stockholders approve 3.5M share increase to equity plan and officer liability limitation","bullets":["Class III directors Blizard, Burgess, O'Brien elected; Burgess received only 9.75M votes for vs 19.54M withheld.","Equity plan amendment approved (20.03M for, 9.25M against); adds 3.5M shares, removes evergreen provision.","Charter amendment to limit officer liability passed (23.84M for, 5.41M against).","Non-binding say-on-pay approved with 23.03M for; annual frequency selected (26.94M for 1-year).","KPMG LLP ratified as auditor for 2025 with 31.84M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-054867","json":"https://secwatch.observer/filing/0001104659-25-054867.json","markdown":"https://secwatch.observer/filing/0001104659-25-054867.md","text":"https://secwatch.observer/filing/0001104659-25-054867.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925054867/0001104659-25-054867-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925054867/tm2516546d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:25:19.459775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}